Cannabis Industry Week: Key Developments Through September 5, 2026

Federal Rescheduling Timeline Remains Uncertain

DEA rescheduling proceedings continue without a firm hearing date, leaving operators in limbo on 280E relief. The administrative law judge assigned to review the proposed move of cannabis from Schedule I to Schedule III hasn't set a formal hearing calendar, according to sources familiar with the docket. Industry analysts expect the earliest possible implementation in Q2 2027. Legal challenges could extend that timeline.

The delay keeps Section 280E of the tax code in force, barring cannabis businesses from deducting ordinary operating expenses. Multi-state operators reported effective tax rates above 70% in recent earnings calls—a structural disadvantage that rescheduling would eliminate. Until then, operators continue lobbying for SAFE Banking Act passage as an interim measure.

For full background on federal cannabis policy developments, see the CannIntel topic hub on Cannabis News Roundup.

State Regulatory Changes Accelerate in Key Markets

California, Ohio, and New York all advanced regulatory reforms this week that reshape operator obligations and market access. The changes reflect a broader trend toward professionalization and tighter oversight as state programs mature.

• California: The Department of Cannabis Control finalized emergency regulations requiring all licensees to implement track-and-trace integration with the state's METRC system by October 15, 2026. Non-compliance triggers automatic license suspension.
• Ohio: The Division of Cannabis Control approved 12 new dual-use licenses, expanding the adult-use market ahead of the November 2026 retail launch. The state received 387 applications for 50 available licenses.
• New York: The Office of Cannabis Management announced it will prioritize conditional cultivator license conversions in Q4 2026, a move expected to add 40-60 new growers to the state's supply chain by year-end.

Each state is working through the tension between expanding access and maintaining regulatory control. Regulators are front-loading compliance requirements to avoid the enforcement backlog that plagued earlier markets.

MSO Earnings Signal Margin Pressure and Consolidation

Three of the top five multi-state operators reported Q2 2026 earnings this week, with gross margins declining 200-400 basis points year-over-year. The margin compression stems from wholesale price deflation in mature markets and rising labor costs tied to union agreements in California, New York, and Illinois.

Trulieve Cannabis reported revenue of $287 million for Q2 2026, down 3% sequentially, with EBITDA margins at 28%—a 320-basis-point decline from Q2 2025. The company attributed the pressure to Florida wholesale pricing and higher compliance costs tied to the state's THC potency cap debate.

Curaleaf Holdings posted $341 million in revenue, flat sequentially, but announced plans to divest its Arizona and Oregon assets to focus capital on higher-margin East Coast markets. The move signals a broader industry shift. Operators are choosing geographic concentration over footprint as they chase profitability.

Green Thumb Industries outperformed peers with 6% sequential revenue growth to $298 million, driven by Illinois and Pennsylvania same-store sales gains. The company maintained EBITDA margins at 32%, the highest among top-tier MSOs, and reiterated full-year 2026 guidance.

Analysts expect further M&A activity in Q4 2026 as undercapitalized operators face refinancing pressure. The next signal: whether distressed-asset buyers emerge or whether consolidation stalls due to federal banking restrictions.